Defendant Name:
TherapeuticsMD, Inc.
Defendant Type:
Public Company
SIC Code:
1311
CUSIP:
88338N10
Document Reference:
34-86708
Document Details
Legal Case Name
In the Matter of TherapeuticsMD, Inc.
Document Name
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing Civil Penalties and a Cease-and-Desist Order
Document Date
20-Aug-2019
Document Format
Administrative Proceeding
Allegation Type
Issuer Reporting and Disclosure
Document Summary
On August 20, 2019, the SEC instituted settled administrative and cease and desist proceedings against TherapeuticsMD, Inc. ("TherapeuticsMD"). The SEC stated: "This matter concerns selective disclosures of material nonpublic information on two separate occasions in 2017 by TherapeuticsMD to sell-side research analysts who covered the Company. Both disclosures related to the Company's interactions with the Food and Drug Administration ("FDA") concerning potential approval of a TherapeuticsMD drug, TX-004HR."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Cooperation Before the Resolution
Remedial Acts or Efforts Before the Resolution
Monetary Penalties:
Civil Penalty
Individual:
$200,000.00
Shared: